Pluripotent stem cell-derived cardiomyocyte transplantation: marching from bench to bedside
Science China Life Sciences · 2025
DOI: 10.1007/s11427-024-2801-x ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Science China Life Sciences, 2025. Verfasst von Yi Hong und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physiology and Pathophysiology, School of Basic Medical Sciences, State Key Laboratory of Vascular Homeostasis and Remodeling, Beijing …. Hauptthemen laut MEDLINE: Myocytes, Cardiac, Pluripotent Stem Cells, Stem Cell Transplantation. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 220 Literaturangaben.
Abstract (Originalsprache)
Cardiovascular diseases such as myocardial infarction, heart failure, and cardiomyopathy, persist as a leading global cause of death. Current treatment options have inherent limitations, particularly in terms of cardiac regeneration due to the limited regenerative capacity of adult human hearts. The transplantation of pluripotent stem cell-derived cardiomyocytes (PSC-CMs) has emerged as a promising and potential solution to address this challenge. This review aims to summarize the latest advancements and prospects of PSC-CM transplantation (PCT), along with the existing constraints, such as immune rejection and engraftment arrhythmias, and corresponding solutions. Encompassing a comprehensive range from fundamental research findings and preclinical experiments to ongoing clinical trials, we hope to offer insights into PCT from bench to bedside.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Physiology and Pathophysiology, School of Basic Medical Sciences, State Key Laboratory of Vascular Homeostasis and Remodeling, Beijing Advanced Center of Cellular Homeostasis and Aging-Related Diseases, Ce…
- Department of Education, Peking University First Hospital, Peking University, Beijing, 100035, China.
- TianXinFu (Beijing) Medical Appliance Co., Ltd., Beijing, 102200, China.
- Department of Stem Cells and Developmental Biology, Cell Science Research Center, Royan Institute for Stem Cell Biology and Technology, The Academic Center for Education, Culture and Research, Tehran, 14155-4364, Iran.
- Department of Cardiology and Institute of Vascular Medicine, Key Laboratory of Molecular Cardiovascular Science, Ministry of Education, Peking University Third Hospital, Beijing, 100191, China. tangyida@bjmu.edu.cn.
- State Key Laboratory of Female Fertility Promotion, Department of Obstetrics and Gynecology, Peking University Third Hospital, Beijing, 100191, China. xi_wang@pku.edu.cn.
Zitieren
APA
Hong, Y., Liu, J., Wang, W., Li, H., Kong, W., Li, X., Zhang, W., Pahlavan, S., Tang, Y. D., Wang, X., & Wang, K. (2025). Pluripotent stem cell-derived cardiomyocyte transplantation: marching from bench to bedside. Science China Life Sciences. https://doi.org/10.1007/s11427-024-2801-x
Vancouver
Hong Y, Liu J, Wang W, Li H, Kong W, Li X, et al. Pluripotent stem cell-derived cardiomyocyte transplantation: marching from bench to bedside. Science China Life Sciences. 2025. doi:10.1007/s11427-024-2801-x
BibTeX
@article{Hong2025,
author = {Hong, Yi and Liu, Jiarui and Wang, Weixuan and Li, Hao and Kong, Weijing and Li, Xiaoxia and Zhang, Wei and Pahlavan, Sara and Tang, Yi-da and Wang, Xi and Wang, Kai},
title = {Pluripotent stem cell-derived cardiomyocyte transplantation: marching from bench to bedside},
journal = {Science China Life Sciences},
year = {2025},
doi = {10.1007/s11427-024-2801-x}
}
EUVIMED